Artificial Oxygen Carrier : Its Front Line

This volume of the Keio University International Symposia for Life Sciences and Medicine contains the proceedings of the 13th symposium held under the sponsorship of the Keio University Medical Science Fund. The fund was est- lished by the generous donation of the late Dr. Mitsunada Sakaguchi. The K...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal : Kobayashi Koichi (Éditeur scientifique)
Collectivité auteur : Keio University international symposium for life sciences and medicine 13 2003 Tokyo (Auteur)
Autres auteurs : Tsuchida Eishun (Éditeur scientifique), Horinouchi Hirohisa (Éditeur scientifique)
Format : Livre
Langue : anglais
Titre complet : Artificial Oxygen Carrier : Its Front Line / [édité par] Koichi Kobayashi, Eishun Tsuchida, Hirohisa Horinouchi.
Édition : 1st ed. 2005.
Publié : Tokyo : Springer Japan , 2005
Collection : Keio university symposia for life sciences and medicine ; 12
Titre de l'ensemble : Keio University International Symposia for Life Sciences and Medicine vol. 12
Accès en ligne : Accès Nantes Université
Accès direct soit depuis les campus via le réseau ou le wifi eduroam soit à distance avec un compte @etu.univ-nantes.fr ou @univ-nantes.fr
Contenu : Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes. Red Blood Cell Substitutes: Past, Present, and Future. Inhaled Nitric Oxide: Update 2003. The Role of p50 in Tissue Oxygen Delivery by Cell-Free Oxygen Carriers. Repetitive Administration of Hemoglobin Raffimer in Experimental Models and Clinical Applications. Oxygen Gradients In Vivo Seen by a High Oxygen Affinity HB Polymer. Oxygen Partition Between Microvessels and Tissue: Significance for the Design of Blood Substitutes. Endothelial Cell Response to Hemoglobin Based Oxygen Carriers. Is the Attenuation of Pathological Reactions Possible?. The Development of a Second-Generation, Designer, Recombinant Hemoglobin. Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers. Successful Ex Vivo Normothermic Liver Perfusion with Purely Artificial Products Using Artificial Blood. Effect of Hemoglobin-Based Blood Substitutes on Nitric Oxide Transport: Mathematical Models. New Strategy for the Preparation of NO-Treated Red Blood Cells as a Blood Substitute. Oxygen-Carrying Plasma Hemoprotein Including Synthetic Heme. Micromechanical Properties of Newly Developed Polyelectrolyte Microcapsules (PEMC). Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen. Oxygen-Dependent and Oxygen-Independent Effects of Perftoran. State of the Art and Challenges in Blood Substitutes Research: A Case Study on Perfluorocarbon-Based Oxygen Carriers. Semifluorinated Alkanes as Stabilizing Agents of Fluorocarbon Emulsions. Possible Role of Artificial Oxygen Carriers in Shock and Trauma. Clinical Needs for Artificial Oxygen Carriers in Anaesthesia. Studies on Red Cell Substitutes in Japan and Future Perspectives
Sujets :
Documents associés : Autre format: Artificial oxygen carrier
LEADER 06493clm a2200733 4500
001 PPN123101581
003 http://www.sudoc.fr/123101581
005 20240531154900.0
010 |a 978-4-431-26651-8 
017 7 0 |a 10.1007/b137855  |2 doi 
035 |a (OCoLC)300260103 
035 |a Springer978-4-431-26651-8 
035 |a Springer-11650-978-4-431-26651-8 
100 |a 20080409d2005 u y0frey0103 ba 
101 0 |a eng 
102 |a JP 
105 |a y ||||1|||| 
135 |a dr||||||||||| 
181 |6 z01  |c txt  |2 rdacontent 
181 1 |6 z01  |a i#  |b xxxe## 
182 |6 z01  |c c  |2 rdamedia 
182 1 |6 z01  |a b 
183 |6 z01  |a ceb  |2 rdamedia 
200 1 |a Artificial Oxygen Carrier  |e Its Front Line  |f [édité par] Koichi Kobayashi, Eishun Tsuchida, Hirohisa Horinouchi. 
205 |a 1st ed. 2005. 
214 0 |a Tokyo  |c Springer Japan  |d 2005 
225 1 |a Keio University International Symposia for Life Sciences and Medicine  |v 12 
230 |a Données textuelles 
303 |a Description d après la consultation, 2013-06-20 
304 |a Titre provenant de l écran d accueil 
305 |a Numérisation de l édition de Sringer Verlag : 2006, ISBN : 978-4-431-22074-9, 4431220747 
307 |a L impression de cette ressource génère 294 p. 
310 |a L'accès complet au document est réservé aux usagers des établissements qui en ont fait l'acquisition 
327 1 |a Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes  |a Red Blood Cell Substitutes: Past, Present, and Future  |a Inhaled Nitric Oxide: Update 2003  |a The Role of p50 in Tissue Oxygen Delivery by Cell-Free Oxygen Carriers  |a Repetitive Administration of Hemoglobin Raffimer in Experimental Models and Clinical Applications  |a Oxygen Gradients In Vivo Seen by a High Oxygen Affinity HB Polymer  |a Oxygen Partition Between Microvessels and Tissue: Significance for the Design of Blood Substitutes  |a Endothelial Cell Response to Hemoglobin Based Oxygen Carriers. Is the Attenuation of Pathological Reactions Possible?  |a The Development of a Second-Generation, Designer, Recombinant Hemoglobin  |a Hemoglobin-Vesicles (HbV) as Artificial Oxygen Carriers  |a Successful Ex Vivo Normothermic Liver Perfusion with Purely Artificial Products Using Artificial Blood  |a Effect of Hemoglobin-Based Blood Substitutes on Nitric Oxide Transport: Mathematical Models  |a New Strategy for the Preparation of NO-Treated Red Blood Cells as a Blood Substitute  |a Oxygen-Carrying Plasma Hemoprotein Including Synthetic Heme  |a Micromechanical Properties of Newly Developed Polyelectrolyte Microcapsules (PEMC)  |a Intravascular Microbubbles: An Ultra-Effective Means of Transporting Oxygen  |a Oxygen-Dependent and Oxygen-Independent Effects of Perftoran  |a State of the Art and Challenges in Blood Substitutes Research: A Case Study on Perfluorocarbon-Based Oxygen Carriers  |a Semifluorinated Alkanes as Stabilizing Agents of Fluorocarbon Emulsions  |a Possible Role of Artificial Oxygen Carriers in Shock and Trauma  |a Clinical Needs for Artificial Oxygen Carriers in Anaesthesia  |a Studies on Red Cell Substitutes in Japan and Future Perspectives 
330 |a This volume of the Keio University International Symposia for Life Sciences and Medicine contains the proceedings of the 13th symposium held under the sponsorship of the Keio University Medical Science Fund. The fund was est- lished by the generous donation of the late Dr. Mitsunada Sakaguchi. The Keio University International Symposia for Life Sciences and Medicine constitute one of the core activities sponsored by the fund,of which the objective is to contribute to the international community by developing human resources, promoting scienti?c knowledge, and encouraging mutual exchange. Each year, the Committee of the International Symposia for Life Sciences and Medicine selects the most signi?cant symposium topics from applications received from the Keio medical community. The publication of the proce- ings is intended to publicize and distribute the information arising from the lively discussions of the most exciting and current issues presented during the symposium. On behalf of the Committee, I am most grateful to the late Dr. Sakaguchi, who made the series of symposia possible. We are also grateful to the prominent speakers for their contribution to this volume. In addition, we would like to acknowledge the ef?cient organizational work performed by the members of the program committee and the staff of the fund. Naoki Aikawa, M. D. , D. M. Sc. , F. A. C. S 
337 |a Nécessite un lecteur de fichier PDF 
410 | |0 048112550  |t Keio university symposia for life sciences and medicine  |v 12 
452 | |0 083308431  |t Artificial oxygen carrier  |o its front line  |f [proceedings of the 13th symposium of the Keio university medical sciences fund]  |c Tokyo  |n Springer  |d 2005  |p 1 vol. (XV-280 p.)  |s Keio University international symposia for life sciences and medicine  |y 4-431-22074-7 
606 |3 PPN040672093  |a Substituts sanguins  |3 PPN040812642  |x Acte de congrès  |2 fmesh 
606 |3 PPN040671003  |a Transport biologique  |3 PPN040812642  |x Acte de congrès  |2 fmesh 
606 |3 PPN029510651  |a Oxygène dans l'organisme  |2 rameau 
606 |3 PPN029929172  |a Sang  |x Substituts  |2 rameau 
606 |3 PPN040753093  |a Oxygène  |3 PPN038961172  |x sang  |3 PPN040812642  |x Acte de congrès  |2 fmesh 
608 |3 PPN02886431X  |a Actes de congrès  |2 rameau 
610 1 |a Medicine & Public Health 
610 2 |a Hematology 
610 2 |a Blood Transfusion Medicine 
615 |a @Medicine  |n 11650; ZDB-2-SME  |2 Springer 
615 |a @Medicine  |n 11650  |2 Springer 
676 |a 616.15  |v 23 
680 |a RB45 
686 |a WH 450  |2 usnlm 
700 1 |a Kobayashi  |b Koichi  |4 340 
702 1 |3 PPN083312544  |a Kobayashi  |b Koichi  |4 340 
702 1 |3 PPN052501086  |a Tsuchida  |b Eishun  |f 1930-....  |4 340 
702 1 |3 PPN083312633  |a Horinouchi  |b Hirohisa  |4 340 
711 1 2 |3 PPN083308423  |a Keio University international symposium for life sciences and medicine  |d 13  |f 2003  |e Tokyo  |4 070 
801 3 |a FR  |b Abes  |c 20200824  |g AFNOR 
801 1 |a DE  |b Springer  |c 20200821  |g AACR2 
856 4 |5 441099901:483217700  |u https://login.budistant.univ-nantes.fr/login?url=https://www.vlebooks.com/vleweb/product/openreader?id=UdN&accId=9254905&isbn=9784431266518 
930 |5 441099901:483217700  |b 441099901  |j g 
991 |5 441099901:483217700  |a Exemplaire modifié automatiquement le 30-09-2019 18:02 
991 |5 441099901:483217700  |a Exemplaire modifié automatiquement. le 10-07-2021 16:22 
998 |a 655114